A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis
Clinical trial NCT06406205 · RECRUITING
Trial details
- NCT number
- NCT06406205
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-25
- Primary completion
- 2027-06-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.